# Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

> **NCT04485286** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Lung Cancer
- Radiation Fibrosis
- Radiation Induced Lung Injury
- Pancreas Cancer

## Interventions

- **DRUG:** [68Ga]CBP8

## Key facts

- **NCT ID:** NCT04485286
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-19
- **Primary completion:** 2027-05
- **Final completion:** 2027-07
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04485286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04485286, "Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04485286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*